Hong Kong-based pharma-genomics firm Prenetics has secured a $10 million Series A investment in a round led by Ping An Ventures, the venture capital arm of Ping An Insurance Group.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
